{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T15:51:56Z","timestamp":1793375516059,"version":"4.5.0"},"reference-count":123,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T00:00:00Z","timestamp":1768003200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T00:00:00Z","timestamp":1768003200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Atheroscler Rep"],"DOI":"10.1007\/s11883-025-01386-9","type":"journal-article","created":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T08:10:05Z","timestamp":1768032605000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Pleiotropic Effects of Statins: Focus on Inflammation, Oxidative Stress and Immunomodulation (Part I)"],"prefix":"10.1007","volume":"28","author":[{"given":"Ali","family":"Mahmoudi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niki","family":"Katsiki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Vrablik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirhossein","family":"Sahebkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,10]]},"reference":[{"key":"1386_CR1","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/8807278","author":"TJ Zhao","year":"2023","unstructured":"Zhao TJ, Luo D, Jiang X, Tang F, Jiang H. Effect of statins on major adverse cardiovascular events in patients with coronary artery spasm: a meta-analysis of the Asia region. Cardiovasc Ther. 2023. https:\/\/doi.org\/10.1155\/2023\/8807278.","journal-title":"Cardiovasc Ther"},{"issue":"12","key":"1386_CR2","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1007\/s40265-024-02105-5","volume":"84","author":"M Banach","year":"2024","unstructured":"Banach M, Reiner \u017d, Surma S, Bajraktari G, Bielecka-Dabrowa A, Bunc M, et al. 2024 recommendations on the optimal use of lipid-lowering therapy in established atherosclerotic cardiovascular disease and following acute coronary syndromes: a position paper of the International Lipid Expert Panel (ILEP). Drugs. 2024;84(12):1541\u201377.","journal-title":"Drugs"},{"key":"1386_CR3","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.coph.2018.01.003","volume":"39","author":"N Katsiki","year":"2018","unstructured":"Katsiki N, Giannoukas AD, Athyros VG, Mikhailidis DP. Lipid-lowering treatment in peripheral artery disease. Curr Opin Pharmacol. 2018;39:19\u201326.","journal-title":"Curr Opin Pharmacol"},{"issue":"16","key":"1386_CR4","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1080\/14656566.2019.1649394","volume":"20","author":"N Katsiki","year":"2019","unstructured":"Katsiki N, P. MD, Banach M. Lipid-lowering agents for concurrent cardiovascular and chronic kidney disease. Expert Opin Pharmacother. 2019;20(16):2007\u201317.","journal-title":"Expert Opin Pharmacother"},{"issue":"1","key":"1386_CR5","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1186\/s12933-022-01684-5","volume":"21","author":"M Banach","year":"2022","unstructured":"Banach M, Surma S, Reiner Z, Katsiki N, Penson PE, Fras Z, et al. Personalized management of dyslipidemias in patients with diabetes\u2014it is time for a new approach (2022). Cardiovasc Diabetol. 2022;21(1):263.","journal-title":"Cardiovasc Diabetol"},{"issue":"32","key":"1386_CR6","doi-asserted-by":"publisher","first-page":"3702","DOI":"10.2174\/0929867330666221129094921","volume":"30","author":"S Aslani","year":"2023","unstructured":"Aslani S, Razi B, Imani D, Mohammadi K, Jamialah-Madi T, Reiner \u017d, et al. Effect of Statins on the blood lipid profile in patients with different cardiovascular diseases: A systematic review with Meta-analysis of randomized clinical trials. Curr Med Chem. 2023;30(32):3702\u201324.","journal-title":"Curr Med Chem"},{"issue":"11","key":"1386_CR7","doi-asserted-by":"publisher","first-page":"2470","DOI":"10.1016\/j.numecd.2022.07.018","volume":"32","author":"XH Yang","year":"2022","unstructured":"Yang XH, Zhang BL, Cheng Y, Fu SK, Jin HM. Statin use and the risk of CVD events, stroke, and all-cause mortality in patients with diabetes: a systematic review and meta-analysis. Nutr Metab Cardiovasc Dis. 2022;32(11):2470\u201382.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"1386_CR8","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.ijcard.2022.12.006","volume":"372","author":"G Kaur","year":"2023","unstructured":"Kaur G, Jones M, Howes L, Hattingh HL. Systematic review and meta-analysis of the association between all-cause mortality and statin therapy in patients with preserved ejection fraction heart failure (HFpEF). Int J Cardiol. 2023;372:63\u201370.","journal-title":"Int J Cardiol"},{"issue":"10","key":"1386_CR9","doi-asserted-by":"publisher","first-page":"103325","DOI":"10.1016\/j.drudis.2022.07.010","volume":"27","author":"F Zahedipour","year":"2022","unstructured":"Zahedipour F, Butler AE, Eid AH, Sahebkar A. Pleiotropic properties of statins via angiogenesis modulation in cardiovascular disease. Drug Discov Today. 2022;27(10):103325.","journal-title":"Drug Discov Today"},{"issue":"7","key":"1386_CR10","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1093\/jpp\/rgad024","volume":"75","author":"E Aminifar","year":"2023","unstructured":"Aminifar E, Tavakkol Afshari HS, Sathyapalan T, Abbasifard M, Sahebkar A. The pleiotropic effects of statins in rheumatoid arthritis. J Pharm Pharmacol. 2023;75(7):910\u201320.","journal-title":"J Pharm Pharmacol"},{"key":"1386_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jprot.2022.104788","author":"B Bohn","year":"2023","unstructured":"Bohn B, Lutsey PL, Tang W, Pankow JS, Norby FL, Yu B, et al. A proteomic approach for investigating the pleiotropic effects of statins in the atherosclerosis risk in communities (ARIC) study. J Proteomics. 2023. https:\/\/doi.org\/10.1016\/j.jprot.2022.104788.","journal-title":"J Proteomics"},{"issue":"6","key":"1386_CR12","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1007\/s00204-023-03492-6","volume":"97","author":"CA German","year":"2023","unstructured":"German CA, Liao JK. Understanding the molecular mechanisms of statin pleiotropic effects. Arch Toxicol. 2023;97(6):1529\u201345.","journal-title":"Arch Toxicol"},{"key":"1386_CR13","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.atherosclerosis.2016.07.897","volume":"253","author":"P Chru\u015bciel","year":"2016","unstructured":"Chru\u015bciel P, Sahebkar A, Rembek-Wieliczko M, Serban MC, Ursoniu S, Mikhailidis DP, et al. Impact of Statin therapy on plasma adiponectin concentrations: A systematic review and meta-analysis of 43 randomized controlled trial arms. Atherosclerosis. 2016;253:194\u2013208.","journal-title":"Atherosclerosis"},{"issue":"2","key":"1386_CR14","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1002\/jcsm.12654","volume":"12","author":"H Mollazadeh","year":"2021","unstructured":"Mollazadeh H, Tavana E, Fanni G, Bo S, Banach M, Pirro M, et al. Effects of Statins on mitochondrial pathways. J Cachexia Sarcopenia Muscle. 2021;12(2):237\u201351.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"1386_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2023.155659","author":"A Sahebkar","year":"2023","unstructured":"Sahebkar A, Foroutan Z, Katsiki N, Jamialahmadi T, Mantzoros CS. Ferroptosis, a new pathogenetic mechanism in cardiometabolic diseases and cancer: is there a role for statin therapy? Metab Clin Exp. 2023. https:\/\/doi.org\/10.1016\/j.metabol.2023.155659.","journal-title":"Metab Clin Exp"},{"key":"1386_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/srep09902","author":"C Serban","year":"2015","unstructured":"Serban C, Sahebkar A, Ursoniu S, Mikhailidis DP, Rizzo M, Lip GYH, et al. A systematic review and meta-analysis of the effect of statins on plasma asymmetric dimethylarginine concentrations. Sci Rep. 2015. https:\/\/doi.org\/10.1038\/srep09902.","journal-title":"Sci Rep"},{"issue":"5","key":"1386_CR17","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s40256-023-00594-5","volume":"23","author":"DT Michaeli","year":"2023","unstructured":"Michaeli DT, Michaeli JC, Albers S, Boch T, Michaeli T. Established and emerging lipid-lowering drugs for primary and secondary cardiovascular prevention. Am J Cardiovasc Drugs. 2023;23(5):477\u201395.","journal-title":"Am J Cardiovasc Drugs"},{"issue":"8","key":"1386_CR18","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1016\/j.clinthera.2013.06.019","volume":"35","author":"A Sahebkar","year":"2013","unstructured":"Sahebkar A, Watts GF. New LDL-cholesterol lowering therapies: pharmacology, clinical trials, and relevance to acute coronary syndromes. Clin Ther. 2013;35(8):1082\u201398.","journal-title":"Clin Ther"},{"issue":"6","key":"1386_CR19","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s10557-013-6479-4","volume":"27","author":"A Sahebkar","year":"2013","unstructured":"Sahebkar A, Watts GF. New therapies targeting ApoB metabolism for high-risk patients with inherited dyslipidaemias: what can the clinician expect? Cardiovasc Drugs Ther. 2013;27(6):559\u201367.","journal-title":"Cardiovasc Drugs Ther"},{"issue":"2","key":"1386_CR20","doi-asserted-by":"publisher","first-page":"e0280741","DOI":"10.1371\/journal.pone.0280741","volume":"18","author":"E Wo\u017aniak","year":"2023","unstructured":"Wo\u017aniak E, Broncel M, Niedzielski M, Wo\u017aniak A, Gorzelak-Pabi\u015b P. The effect of lipid-lowering therapies on the pro-inflammatory and anti-inflammatory properties of vascular endothelial cells. PLoS One. 2023;18(2):e0280741.","journal-title":"PLoS One"},{"key":"1386_CR21","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.phrs.2018.08.014","volume":"135","author":"A Bahrami","year":"2018","unstructured":"Bahrami A, Parsamanesh N, Atkin SL, Banach M, Sahebkar A. Effect of statins on toll-like receptors: a new insight to pleiotropic effects. Pharmacol Res. 2018;135:230\u20138.","journal-title":"Pharmacol Res"},{"key":"1386_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11051313","author":"A Mansouri","year":"2022","unstructured":"Mansouri A, Reiner \u017d, Ruscica M, Tedeschi-Reiner E, Radbakhsh S, Ekta MB, et al. Antioxidant effects of statins by modulating Nrf2 and Nrf2\/HO-1 signaling in different diseases. J Clin Med. 2022. https:\/\/doi.org\/10.3390\/jcm11051313.","journal-title":"J Clin Med"},{"issue":"2","key":"1386_CR23","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1093\/ehjcvp\/pvac047","volume":"9","author":"E Greca","year":"2023","unstructured":"Greca E, Kacimi O, Poudel S, Wireko AA, Abdul-Rahman T, Michel G, et al. Immunomodulatory effect of different Statin regimens on regulatory T-cells in patients with acute coronary syndrome: a systematic review and network meta-analysis of randomized clinical trials. Eur Heart J Cardiovasc Pharmacother. 2023;9(2):122\u20138.","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"issue":"5","key":"1386_CR24","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/s44161-023-00267-1","volume":"2","author":"C Liu","year":"2023","unstructured":"Liu C, Shen M, Tan WLW, Chen IY, Liu Y, Yu X, et al. Statins improve endothelial function via suppression of epigenetic-driven EndMT. Nat Cardiovasc Res. 2023;2(5):467\u201385.","journal-title":"Nat Cardiovasc Res"},{"issue":"2","key":"1386_CR25","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.atherosclerosis.2015.05.022","volume":"241","author":"A Sahebkar","year":"2015","unstructured":"Sahebkar A, Kotani K, Serban C, Ursoniu S, Mikhailidis DP, Jones SR, et al. Statin therapy reduces plasma endothelin-1 concentrations: A meta-analysis of 15 randomized controlled trials. Atherosclerosis. 2015;241(2):433\u201342.","journal-title":"Atherosclerosis"},{"key":"1386_CR26","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/5548310","author":"M Alidadi","year":"2021","unstructured":"Alidadi M, Montecucco F, Jamialahmadi T, Al-Rasadi K, Johnston TP, Sahebkar A. Beneficial effect of statin therapy on arterial stiffness. Biomed Res Int. 2021. https:\/\/doi.org\/10.1155\/2021\/5548310.","journal-title":"Biomed Res Int"},{"key":"1386_CR27","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1146\/annurev-med-051812-145304","volume":"65","author":"A Phillip Owens","year":"2014","unstructured":"Phillip Owens A, Mackman N. The antithrombotic effects of statins. Annu Rev Med. 2014;65:433\u201345.","journal-title":"Annu Rev Med"},{"issue":"3","key":"1386_CR28","first-page":"546","volume":"114","author":"A Sahebkar","year":"2015","unstructured":"Sahebkar A, Serban C, Mikhailidis DP, Undas A, Lip GY, Muntner P, et al. Association between Statin use and plasma D-dimer levels. A systematic review and meta-analysis of randomised controlled trials. Thromb Haemost. 2015;114(3):546\u201357.","journal-title":"Thromb Haemost"},{"issue":"3","key":"1386_CR29","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1160\/th15-08-0620","volume":"115","author":"A Sahebkar","year":"2016","unstructured":"Sahebkar A, Serban C, Ursoniu S, Mikhailidis DP, Undas A, Lip GYH, et al. The impact of Statin therapy on plasma levels of von Willebrand factor antigen: systematic review and meta-analysis of randomised placebo-controlled trials. Thromb Haemost. 2016;115(3):520\u201332.","journal-title":"Thromb Haemost"},{"issue":"4","key":"1386_CR30","first-page":"495","volume":"16","author":"SE van Rosendael","year":"2023","unstructured":"van Rosendael SE, van den Hoogen IJ, Lin FY, Andreini D, Al-Mallah MH, Budoff MJ, et al. Clinical and coronary plaque predictors of atherosclerotic nonresponse to statin therapy. JACC: Cardiovascular Imaging. 2023;16(4):495\u2013504.","journal-title":"JACC: Cardiovascular Imaging"},{"issue":"1","key":"1386_CR31","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.atherosclerosis.2005.10.015","volume":"188","author":"NR Veillard","year":"2006","unstructured":"Veillard NR, Braunersreuther V, Arnaud C, Burger F, Pelli G, Steffens S, et al. Simvastatin modulates chemokine and chemokine receptor expression by geranylgeranyl isoprenoid pathway in human endothelial cells and macrophages. Atherosclerosis. 2006;188(1):51\u20138.","journal-title":"Atherosclerosis"},{"issue":"3","key":"1386_CR32","first-page":"475","volume":"28","author":"DD Peng","year":"2008","unstructured":"Peng DD, Li ZL. [Effect of Simvastatin on monocyte CX3CR1 expression in patients with acute coronary syndrome]. Nan Fang Yi Ke Da Xue Xue Bao. 2008;28(3):475\u20137.","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"issue":"12","key":"1386_CR33","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1111\/eci.12183","volume":"43","author":"AS Jaipersad","year":"2013","unstructured":"Jaipersad AS, Shantsila E, Blann A, Lip GYH. The effect of statin therapy withdrawal on monocyte subsets. Eur J Clin Invest. 2013;43(12):1307\u201313.","journal-title":"Eur J Clin Invest"},{"issue":"2","key":"1386_CR34","first-page":"189","volume":"24","author":"T Walter","year":"2010","unstructured":"Walter T, Suselbeck T, Borggrefe M, Swoboda S, Hoffmeister HM, Dempfle CE. Effect of atorvastatin on cellular adhesion molecules on leukocytes in patients with normocholesterolemic coronary artery disease. Vivo. 2010;24(2):189\u201393.","journal-title":"Vivo"},{"issue":"2","key":"1386_CR35","doi-asserted-by":"publisher","first-page":"185","DOI":"10.33549\/physiolres.931132","volume":"57","author":"T Stulc","year":"2008","unstructured":"Stulc T, Vrabl\u00edk M, Kasalov\u00e1 Z, Marinov I, Svobodov\u00e1 H, Ceska R. Leukocyte and endothelial adhesion molecules in patients with hypercholesterolemia: the effect of atorvastatin treatment. Physiol Res. 2008;57(2):185\u201394.","journal-title":"Physiol Res"},{"issue":"4","key":"1386_CR36","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1111\/1755-5922.12126","volume":"33","author":"A Cerda","year":"2015","unstructured":"Cerda A, Rodrigues AC, Alves C, Genvigir FDV, Fajardo CM, Dorea EL, et al. Modulation of adhesion molecules by Cholesterol-Lowering therapy in mononuclear cells from hypercholesterolemic patients. Cardiovasc Ther. 2015;33(4):168\u201376.","journal-title":"Cardiovasc Ther"},{"issue":"22","key":"1386_CR37","doi-asserted-by":"publisher","first-page":"12480","DOI":"10.3390\/ijms222212480","volume":"22","author":"R Linnenberger","year":"2021","unstructured":"Linnenberger R, Hoppst\u00e4dter J, Wrublewsky S, Ampofo E, Kiemer AK. Statins and bempedoic acid: different actions of cholesterol inhibitors on macrophage activation. Int J Mol Sci. 2021;22(22):12480.","journal-title":"Int J Mol Sci"},{"key":"1386_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/cells12151961","author":"W Alkakhan","year":"2023","unstructured":"Alkakhan W, Farrar N, Sikora V, Emecen-Huja P, Huja SS, Yilmaz \u00d6, et al. Statins modulate microenvironmental cues driving macrophage polarization in simulated periodontal inflammation. Cells. 2023. https:\/\/doi.org\/10.3390\/cells12151961.","journal-title":"Cells"},{"issue":"8","key":"1386_CR39","first-page":"1023","volume":"24","author":"P Arya","year":"2021","unstructured":"Arya P, Nabi S, Bhandari U. Modulatory role of atorvastatin against high-fat diet and zymosan-induced activation of TLR2\/NF-\u0199B signaling pathway in C57BL\/6 mice. Iran J Basic Med Sci. 2021;24(8):1023\u201332.","journal-title":"Iran J Basic Med Sci"},{"issue":"4","key":"1386_CR40","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s10753-010-9234-z","volume":"34","author":"N Liu","year":"2011","unstructured":"Liu N, Liu J, Ji Y, Lu P, Wang C, Guo F. C-reactive protein induces TNF-\u03b1 secretion by p38 MAPK\u2013TLR4 signal pathway in rat vascular smooth muscle cells. Inflammation. 2011;34(4):283\u201390.","journal-title":"Inflammation"},{"issue":"1","key":"1386_CR41","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.cccn.2004.10.007","volume":"353","author":"H-R Wang","year":"2005","unstructured":"Wang H-R, Li J-J, Huang C-X, Jiang H. Fluvastatin inhibits the expression of tumor necrosis factor-+A7E and activation of nuclear factor-+A7o-B in human endothelial cells stimulated by C-reactive protein. Clin Chim Acta. 2005;353(1):53\u201360.","journal-title":"Clin Chim Acta"},{"issue":"18","key":"1386_CR42","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1056\/NEJMoa0707402","volume":"359","author":"J Zacho","year":"2008","unstructured":"Zacho J, Tybjaerg-Hansen A, Jensen JS, Grande P, Sillesen H, Nordestgaard BG. Genetically elevated C-reactive protein and ischemic vascular disease. N Engl J Med. 2008;359(18):1897\u2013908.","journal-title":"N Engl J Med"},{"issue":"9","key":"1386_CR43","doi-asserted-by":"publisher","first-page":"4935","DOI":"10.1007\/s12035-023-03371-2","volume":"60","author":"G Lietzau","year":"2023","unstructured":"Lietzau G, Sienkiewicz W, Karwacki Z, Dziewi\u0105tkowski J, Kaleczyc J, Kowia\u0144ski P. The effect of Simvastatin on the dynamics of NF-\u03baB-regulated neurodegenerative and neuroprotective processes in the acute phase of ischemic stroke. Mol Neurobiol. 2023;60(9):4935\u201351.","journal-title":"Mol Neurobiol"},{"key":"1386_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1166123","author":"JM Santoyo","year":"2023","unstructured":"Santoyo JM, Noguera JA, Avil\u00e9s F, Hern\u00e1ndez-Caselles T, de Paco-Matallana C, Delgado JL, et al. Pravastatin reduces plasma levels of extracellular vesicles in pregnancies at high risk of term preeclampsia. Front Pharmacol. 2023. https:\/\/doi.org\/10.3389\/fphar.2023.1166123.","journal-title":"Front Pharmacol"},{"key":"1386_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1035589","author":"F Gonz\u00e1lez-Herrera","year":"2023","unstructured":"Gonz\u00e1lez-Herrera F, Clayton NS, Guzm\u00e1n-Rivera D, Carrillo I, Castillo C, Catal\u00e1n M, et al. Statins change the cytokine profile in Trypanosoma cruzi-infected U937 macrophages and murine cardiac tissue through Rho-associated kinases inhibition. Front Immunol. 2023. https:\/\/doi.org\/10.3389\/fimmu.2022.1035589.","journal-title":"Front Immunol"},{"issue":"3","key":"1386_CR46","doi-asserted-by":"publisher","first-page":"581","DOI":"10.3897\/pharmacia.70.e109800","volume":"70","author":"HA Al-hussaniy","year":"2023","unstructured":"Al-hussaniy HA, Al-Shammari AH, Sameer HN, Oraibi AI. The relationship between statin therapy and adipocytokine\/inflammatory mediators in dyslipidemic nondiabetic patients: a comparative study. Pharmacia. 2023;70(3):581\u20135.","journal-title":"Pharmacia"},{"issue":"3","key":"1386_CR47","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1097\/FJC.0000000000001445","volume":"82","author":"F Ahmad","year":"2023","unstructured":"Ahmad F, Karim A, Khan J, Qaisar R. Statin therapy induces gut leakage and neuromuscular disjunction in patients with chronic heart failure. J Cardiovasc Pharmacol. 2023;82(3):189\u201395.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"8","key":"1386_CR48","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.hlc.2023.04.300","volume":"32","author":"WB He","year":"2023","unstructured":"He WB, Ko HTK, Curtis AJ, Zoungas S, Woods RL, Tonkin A, et al. The effects of statins on cardiovascular and inflammatory biomarkers in primary prevention: a systematic review and meta-analysis. Heart Lung Circ. 2023;32(8):938\u201348.","journal-title":"Heart Lung Circ"},{"issue":"2","key":"1386_CR49","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.amjcard.2005.11.014","volume":"97","author":"S Mora","year":"2006","unstructured":"Mora S, Ridker PM. Justification for the use of statins in primary prevention: an intervention trial evaluating Rosuvastatin (JUPITER)\u2014can C-reactive protein be used to target statin therapy in primary prevention? Am J Cardiol. 2006;97(2):33\u201341.","journal-title":"Am J Cardiol"},{"issue":"20","key":"1386_CR50","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1161\/CIRCULATIONAHA.117.028271","volume":"135","author":"PM Ridker","year":"2017","unstructured":"Ridker PM, Lonn E, Paynter NP, Glynn R, Yusuf S. Primary prevention with statin therapy in the elderly: new meta-analyses from the contemporary JUPITER and HOPE-3 randomized trials. Circulation. 2017;135(20):1979\u201381.","journal-title":"Circulation"},{"issue":"3","key":"1386_CR51","first-page":"266","volume":"5","author":"A Lamy","year":"2019","unstructured":"Lamy A, Lonn E, Tong W, Swaminathan B, Jung H, Gafni A, et al. The cost implication of primary prevention in the HOPE 3 trial. Eur Heart J. 2019;5(3):266\u201371.","journal-title":"Eur Heart J"},{"issue":"4","key":"1386_CR52","first-page":"e201635","volume":"2016","author":"MA Kashef","year":"2016","unstructured":"Kashef MA, Giugliano G. Legacy effect of statins: 20-year follow up of the West of Scotland Coronary Prevention Study (WOSCOPS). Global Cardiology Science & Practice. 2016;2016(4):e201635.","journal-title":"Global Cardiology Science & Practice"},{"issue":"3, Supplement","key":"1386_CR53","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S0002-9149(02)03144-2","volume":"91","author":"D Harrison","year":"2003","unstructured":"Harrison D, Griendling KK, Landmesser U, Hornig B, Drexler H. Role of oxidative stress in atherosclerosis. Am J Cardiol. 2003;91(3, Supplement):7\u201311.","journal-title":"Am J Cardiol"},{"issue":"2","key":"1386_CR54","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3988\/jcn.2014.10.2.140","volume":"10","author":"GJ Moon","year":"2014","unstructured":"Moon GJ, Kim SJ, Cho YH, Ryoo S, Bang OY. Antioxidant effects of statins in patients with atherosclerotic cerebrovascular disease. J Clin Neurol. 2014;10(2):140\u20137.","journal-title":"J Clin Neurol"},{"key":"1386_CR55","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.plipres.2015.08.003","volume":"60","author":"G Ferretti","year":"2015","unstructured":"Ferretti G, Bacchetti T, Sahebkar A. Effect of statin therapy on paraoxonase-1 status: a systematic review and meta-analysis of 25 clinical trials. Prog Lipid Res. 2015;60:50\u201373.","journal-title":"Prog Lipid Res"},{"issue":"4","key":"1386_CR56","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s11745-010-3517-x","volume":"46","author":"SMR Parizadeh","year":"2011","unstructured":"Parizadeh SMR, Azarpazhooh MR, Moohebati M, Nematy M, Ghayour-Mobarhan M, Tavallaie S, et al. Simvastatin therapy reduces prooxidant-antioxidant balance: results of a placebo-controlled cross-over trial. Lipids. 2011;46(4):333\u201340.","journal-title":"Lipids"},{"key":"1386_CR57","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231911446","author":"A Morotti","year":"2022","unstructured":"Morotti A, Barale C, Melchionda E, Russo I. Platelet redox imbalance in hypercholesterolemia: a big problem for a small cell. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms231911446.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1386_CR58","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ejphar.2013.04.025","volume":"711","author":"R Mahalwar","year":"2013","unstructured":"Mahalwar R, Khanna D. Pleiotropic antioxidant potential of rosuvastatin in preventing cardiovascular disorders. Eur J Pharmacol. 2013;711(1):57\u201362.","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"1386_CR59","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s11010-017-3099-5","volume":"437","author":"T Nikolic","year":"2018","unstructured":"Nikolic T, Zivkovic V, Srejovic I, Stojic I, Jeremic N, Jeremic J, et al. Effects of Atorvastatin and Simvastatin on oxidative stress in diet-induced hyperhomocysteinemia in Wistar albino rats: a comparative study. Mol Cell Biochem. 2018;437(1):109\u201318.","journal-title":"Mol Cell Biochem"},{"issue":"12","key":"1386_CR60","doi-asserted-by":"publisher","first-page":"2642","DOI":"10.1161\/ATVBAHA.107.154492","volume":"27","author":"I Kosmidou","year":"2007","unstructured":"Kosmidou I, Moore JP, Weber M, Searles CD. Statin treatment and 3\u2019 polyadenylation of eNOS mRNA. Arterioscler Thromb Vasc Biol. 2007;27(12):2642\u20139.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1386_CR61","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8122051","author":"AM Gorabi","year":"2019","unstructured":"Gorabi AM, Kiaie N, Hajighasemi S, Banach M, Penson PE, Jamialahmadi T, et al. Statin-induced nitric oxide signaling: mechanisms and therapeutic implications. J Clin Med. 2019. https:\/\/doi.org\/10.3390\/jcm8122051.","journal-title":"J Clin Med"},{"issue":"2","key":"1386_CR62","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.niox.2012.05.006","volume":"27","author":"IM Garc\u00eda","year":"2012","unstructured":"Garc\u00eda IM, Mazzei L, Benard\u00f3n ME, Oliveros L, Cuello-Carri\u00f3n FD, Gil Lorenzo A, et al. Caveolin-1-eNOS\/Hsp70 interactions mediate rosuvastatin antifibrotic effects in neonatal obstructive nephropathy. Nitric Oxide. 2012;27(2):95\u2013105.","journal-title":"Nitric Oxide"},{"issue":"1","key":"1386_CR63","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ijcard.2010.10.029","volume":"156","author":"C Aoki","year":"2012","unstructured":"Aoki C, Nakano A, Tanaka S, Yanagi K, Ohta S, Jojima T, et al. Fluvastatin upregulates endothelial nitric oxide synthase activity via enhancement of its phosphorylation and expression and via an increase in tetrahydrobiopterin in vascular endothelial cells. Int J Cardiol. 2012;156(1):55\u201361.","journal-title":"Int J Cardiol"},{"issue":"8","key":"1386_CR64","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1007\/s40265-021-01510-4","volume":"81","author":"S Dehnavi","year":"2021","unstructured":"Dehnavi S, Kiani A, Sadeghi M, Biregani AF, Banach M, Atkin SL, et al. Targeting AMPK by statins: A potential therapeutic approach. Drugs. 2021;81(8):923\u201333.","journal-title":"Drugs"},{"issue":"4","key":"1386_CR65","doi-asserted-by":"publisher","first-page":"e22263","DOI":"10.1096\/fj.202101654RR","volume":"36","author":"L Yu","year":"2022","unstructured":"Yu L, Liu S, Zhou R, Sun H, Su X, Liu Q, et al. Atorvastatin inhibits neuronal apoptosis via activating cAMP\/PKA\/p-CREB\/BDNF pathway in hypoxic-ischemic neonatal rats. FASEB J. 2022;36(4):e22263.","journal-title":"FASEB J"},{"issue":"1","key":"1386_CR66","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.repce.2015.12.016","volume":"35","author":"S Costa","year":"2016","unstructured":"Costa S, Reina-Couto M, Albino-Teixeira A, Sousa T. Statins and oxidative stress in chronic heart failure. Revista Portuguesa De Cardiologia (English Edition). 2016;35(1):41\u201357.","journal-title":"Revista Portuguesa De Cardiologia (English Edition)"},{"issue":"8","key":"1386_CR67","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1089\/ars.2013.5430","volume":"20","author":"M Margaritis","year":"2014","unstructured":"Margaritis M, Channon KM, Antoniades C. Statins as regulators of redox state in the vascular endothelium: beyond lipid lowering. Antioxid Redox Signal. 2014;20(8):1198\u2013215.","journal-title":"Antioxid Redox Signal"},{"issue":"1","key":"1386_CR68","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.atherosclerosis.2010.08.056","volume":"213","author":"C Roberto","year":"2010","unstructured":"Roberto C, Pasquale P, Serena DS, Simona B, Valerio S, Laura N, et al. Atorvastatin inhibits oxidative stress via adiponectin-mediated NADPH oxidase down-regulation in hypercholesterolemic patients. Atherosclerosis. 2010;213(1):225\u201334.","journal-title":"Atherosclerosis"},{"key":"1386_CR69","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.lfs.2019.01.043","volume":"221","author":"T Bruder-Nascimento","year":"2019","unstructured":"Bruder-Nascimento T, Callera GE, Montezano AC, Belin de Chantemele EJ, Tostes RC, Touyz RM. Atorvastatin inhibits pro-inflammatory actions of aldosterone in vascular smooth muscle cells by reducing oxidative stress. Life Sci. 2019;221:29\u201334.","journal-title":"Life Sci"},{"key":"1386_CR70","doi-asserted-by":"publisher","first-page":"102539","DOI":"10.1016\/j.redox.2022.102539","volume":"58","author":"M Waldeck-Weiermair","year":"2022","unstructured":"Waldeck-Weiermair M, Yadav S, Kaynert J, Thulabandu VR, Pandey AK, Spyropoulos F, et al. Differential endothelial hydrogen peroxide signaling via Nox isoforms: critical roles for Rac1 and modulation by statins. Redox Biol. 2022;58:102539.","journal-title":"Redox Biol"},{"issue":"16","key":"1386_CR71","doi-asserted-by":"publisher","first-page":"3719","DOI":"10.1111\/febs.12893","volume":"281","author":"AK Kanugula","year":"2014","unstructured":"Kanugula AK, Gollavilli PN, Vasamsetti SB, Karnewar S, Gopoju R, Ummanni R, et al. Statin-induced inhibition of breast cancer proliferation and invasion involves attenuation of iron transport: intermediacy of nitric oxide and antioxidant defence mechanisms. FEBS J. 2014;281(16):3719\u201338.","journal-title":"FEBS J"},{"issue":"11","key":"1386_CR72","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1161\/ATVBAHA.110.210500","volume":"30","author":"H Ota","year":"2010","unstructured":"Ota H, Eto M, Kano MR, Kahyo T, Setou M, Ogawa S, et al. Induction of endothelial nitric oxide synthase, SIRT1, and catalase by statins inhibits endothelial senescence through the Akt pathway. Arterioscler Thromb Vasc Biol. 2010;30(11):2205\u201311.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"1386_CR73","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.bbrc.2004.10.123","volume":"325","author":"N Grosser","year":"2004","unstructured":"Grosser N, Erdmann K, Hemmerle A, Berndt G, Hinkelmann U, Smith G, et al. Rosuvastatin upregulates the antioxidant defense protein Heme oxygenase-1. Biochem Biophys Res Commun. 2004;325(3):871\u20136.","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"1386_CR74","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/S1734-1140(09)70146-X","volume":"61","author":"A Nagila","year":"2009","unstructured":"Nagila A, Permpongpaiboon T, Tantrarongroj S, Porapakkham P, Chinwattana K, Deakin S, et al. Effect of Atorvastatin on paraoxonase1 (PON1) and oxidative status. Pharmacol Rep. 2009;61(5):892\u20138.","journal-title":"Pharmacol Rep"},{"issue":"7","key":"1386_CR75","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1161\/01.CIR.0000138743.09012.93","volume":"110","author":"J Haendeler","year":"2004","unstructured":"Haendeler J, Hoffmann J, Zeiher AM, Dimmeler S. Antioxidant effects of statins via <\u2009i\u2009>\u2009S-nitrosylation and activation of thioredoxin in endothelial cells. Circulation. 2004;110(7):856\u201361.","journal-title":"Circulation"},{"key":"1386_CR76","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/978-981-13-8946-7_26","volume-title":"Modulation of oxidative stress in heart disease","author":"N Shyamala","year":"2019","unstructured":"Shyamala N, Hanumanth SR. Pharmacogenetic implications of Statin therapy on oxidative stress in coronary artery disease. In: Chakraborti S, Dhalla NS, Dikshit M, Ganguly NK, editors. Modulation of oxidative stress in heart disease. Singapore: Springer Singapore; 2019. pp. 629\u201344."},{"issue":"4","key":"1386_CR77","doi-asserted-by":"publisher","first-page":"223","DOI":"10.4070\/kcj.2013.43.4.223","volume":"43","author":"Y-J Lee","year":"2013","unstructured":"Lee Y-J, Koh Y-S, Park HE, Lee HJ, Hwang B-H, Kang M-K, et al. Spatial and Temporal Expression, and Statin responsiveness of Galectin-1 and Galectin-3 in murine atherosclerosis. Korean Circ J. 2013;43(4):223\u201330.","journal-title":"Korean Circ J"},{"key":"1386_CR78","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ebiom.2018.08.039","volume":"35","author":"M Toribio","year":"2018","unstructured":"Toribio M, Fitch KV, Stone L, Zanni MV, Lo J, de Filippi C, et al. Assessing Statin effects on cardiovascular pathways in HIV using a novel proteomics approach: analysis of data from INTREPID, a randomized controlled trial. eBioMedicine. 2018;35:58\u201366.","journal-title":"eBioMedicine"},{"issue":"12","key":"1386_CR79","doi-asserted-by":"publisher","first-page":"16504","DOI":"10.1096\/fj.202001743R","volume":"34","author":"N Itani","year":"2020","unstructured":"Itani N, Skeffington KL, Beck C, Niu YG, Katzilieris-Petras G, Smith N, et al. Protective effects of Pravastatin on the embryonic cardiovascular system during hypoxic development. Faseb J. 2020;34(12):16504\u201315.","journal-title":"Faseb J"},{"key":"1386_CR80","doi-asserted-by":"publisher","first-page":"120966","DOI":"10.1016\/j.lfs.2022.120966","volume":"308","author":"Q Niaz","year":"2022","unstructured":"Niaz Q, Tavangar SM, Mehreen S, Ghazi-Khansari M, Jazaeri F. Evaluation of statins as a new therapy to alleviate chronotropic dysfunction in cirrhotic rats. Life Sci. 2022;308:120966.","journal-title":"Life Sci"},{"issue":"3","key":"1386_CR81","doi-asserted-by":"publisher","first-page":"179","DOI":"10.4103\/ijp.IJP_215_20","volume":"55","author":"C Godbole","year":"2023","unstructured":"Godbole C, Thaker S, Salagre S, Shivane V, Gogtay N, Thatte U. A prospective study to assess the role of paraoxonase 1 genotype and phenotype on the lipid-lowering and antioxidant activity of statins. Indian J Pharmacol. 2023;55(3):179\u201384.","journal-title":"Indian J Pharmacol"},{"issue":"2","key":"1386_CR82","first-page":"104","volume":"17","author":"HG Kang","year":"2021","unstructured":"Kang HG, Cheong JS, Lim IH, Yun KH, Park HY. Antioxidative activity of statins and HDL-PON1 association in lacunar ischemic stroke with and without white matter hyperintensity. Signa Vitae. 2021;17(2):104\u201310.","journal-title":"Signa Vitae"},{"issue":"13","key":"1386_CR83","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.3390\/cells12131679","volume":"12","author":"P Fularski","year":"2023","unstructured":"Fularski P, Krzemi\u0144ska J, Lewandowska N, M\u0142ynarska E, Saar M, Wronka M, et al. Statins in chronic kidney Disease\u2014Effects on atherosclerosis and cellular senescence. Cells. 2023;12(13):1679.","journal-title":"Cells"},{"issue":"8","key":"1386_CR84","first-page":"E338","volume":"30","author":"MK Al-Chlaihawi","year":"2023","unstructured":"Al-Chlaihawi MK, Janabi AM. Potential protective effect of Pitavastatin against doxorubicin-induced cardiotoxicity in male rats. J Popul Ther Clin Pharmacol. 2023;30(8):E338\u201348.","journal-title":"J Popul Ther Clin Pharmacol"},{"issue":"46","key":"1386_CR85","doi-asserted-by":"publisher","first-page":"7040","DOI":"10.2174\/1381612823666170926130338","volume":"23","author":"M Margaritis","year":"2017","unstructured":"Margaritis M, Sanna F, Antoniades C. Statins and oxidative stress in the cardiovascular system. Curr Pharm Des. 2017;23(46):7040\u20137.","journal-title":"Curr Pharm Des"},{"issue":"7","key":"1386_CR86","doi-asserted-by":"publisher","first-page":"206","DOI":"10.3390\/biomedicines8070206","volume":"8","author":"AV Poznyak","year":"2020","unstructured":"Poznyak AV, Grechko AV, Orekhova VA, Khotina V, Ivanova EA, Orekhov AN. NADPH oxidases and their role in atherosclerosis. Biomedicines. 2020;8(7):206.","journal-title":"Biomedicines"},{"issue":"1","key":"1386_CR87","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1046\/j.1523-1755.2003.00744.x","volume":"63","author":"LM Blanco-Colio","year":"2003","unstructured":"Blanco-Colio LM, Tu\u00f1\u00f3n J, Mart\u00edn-Ventura JL, Egido J. Anti-inflammatory and immunomodulatory effects of statins. Kidney Int. 2003;63(1):12\u201323.","journal-title":"Kidney Int"},{"issue":"8","key":"1386_CR88","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1134\/S0006297918080023","volume":"83","author":"TI Arefieva","year":"2018","unstructured":"Arefieva TI, Filatova AY, Potekhina AV, Shchinova AM. Immunotropic effects and proposed mechanism of action for 3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors (Statins). Biochemistry (Moscow). 2018;83(8):874\u201389.","journal-title":"Biochemistry (Moscow)"},{"issue":"1","key":"1386_CR89","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S0021-9150(99)00061-1","volume":"144","author":"G Rothe","year":"1999","unstructured":"Rothe G, Herr AS, St\u00f6hr J, Abletshauser C, Weidinger G, Schmitz G. A more mature phenotype of blood mononuclear phagocytes is induced by Fluvastatin treatment in hypercholesterolemic patients with coronary heart disease. Atherosclerosis. 1999;144(1):251\u201361.","journal-title":"Atherosclerosis"},{"issue":"2","key":"1386_CR90","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.atherosclerosis.2010.06.025","volume":"212","author":"T Imanishi","year":"2010","unstructured":"Imanishi T, Ikejima H, Tsujioka H, Kuroi A, Ishibashi K, Komukai K, et al. Association of monocyte subset counts with coronary fibrous cap thickness in patients with unstable angina pectoris. Atherosclerosis. 2010;212(2):628\u201335.","journal-title":"Atherosclerosis"},{"key":"1386_CR91","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.12659\/MSM.889661","volume":"19","author":"Y Yang","year":"2013","unstructured":"Yang Y, Cui Y, Peng DQ. The role of monocyte phenotype switching in peri-procedural myocardial injury and its involvement in statin therapy. Med Sci Monit. 2013;19:1006\u201312.","journal-title":"Med Sci Monit"},{"issue":"6","key":"1386_CR92","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1189\/jlb.69.6.959","volume":"69","author":"B Wong","year":"2001","unstructured":"Wong B, Lumma WC, Smith AM, Sisko JT, Wright SD, Cai TQ. Statins suppress THP-1 cell migration and secretion of matrix metalloproteinase 9 by inhibiting geranylgeranylation. J Leukoc Biol. 2001;69(6):959\u201362.","journal-title":"J Leukoc Biol"},{"key":"1386_CR93","doi-asserted-by":"crossref","unstructured":"Assis LHP, Dorighello GG, Rentz T, Souza JCd, Vercesi AE. Oliveira HCFd. In vivo Pravastatin treatment reverses hypercholesterolemia induced Mitochondria-Associated membranes contact Sites, foam cell Formation, and phagocytosis in macrophages. Front Mol Biosci. 2022;9.","DOI":"10.3389\/fmolb.2022.839428"},{"issue":"1","key":"1386_CR94","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/imm.12902","volume":"154","author":"R Zeiser","year":"2018","unstructured":"Zeiser R. Immune modulatory effects of statins. Immunology. 2018;154(1):69\u201375.","journal-title":"Immunology"},{"issue":"1","key":"1386_CR95","doi-asserted-by":"publisher","first-page":"17381","DOI":"10.1038\/srep17381","volume":"5","author":"N Zhao","year":"2015","unstructured":"Zhao N, Dong Q, Qian C, Li S, Wu Q-F, Ding D, et al. Lovastatin blocks Kv1.3 channel in human T cells: a new mechanism to explain its immunomodulatory properties. Sci Rep. 2015;5(1):17381.","journal-title":"Sci Rep"},{"issue":"1","key":"1386_CR96","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.cell.2017.11.025","volume":"172","author":"S Bekkering","year":"2018","unstructured":"Bekkering S, Arts RJW, Novakovic B, Kourtzelis I, van der Heijden CDCC, Li Y, et al. Metabolic induction of trained immunity through the mevalonate pathway. Cell. 2018;172(1):135\u2013e469.","journal-title":"Cell"},{"issue":"3","key":"1386_CR97","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1111\/imm.12893","volume":"154","author":"I Singh","year":"2018","unstructured":"Singh I, Samuvel DJ, Choi S, Saxena N, Singh AK, Won J. Combination therapy of lovastatin and AMP-activated protein kinase activator improves mitochondrial and peroxisomal functions and clinical disease in experimental autoimmune encephalomyelitis model. Immunology. 2018;154(3):434\u201351.","journal-title":"Immunology"},{"issue":"1","key":"1386_CR98","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/S0008-8749(03)00148-5","volume":"223","author":"D Sun","year":"2003","unstructured":"Sun D, Fernandes G. Lovastatin inhibits bone marrow-derived dendritic cell maturation and upregulates proinflammatory cytokine production. Cell Immunol. 2003;223(1):52\u201362.","journal-title":"Cell Immunol"},{"issue":"2","key":"1386_CR99","doi-asserted-by":"publisher","first-page":"107","DOI":"10.32604\/biocell.2009.33.107","volume":"33","author":"CS Lee","year":"2009","unstructured":"Lee CS, Shin YJ, Won C, Lee YS, Park CG, Ye SK, et al. Simvastatin acts as an inhibitor of interferon gamma-induced cycloxygenase-2 expression in human THP-1 cells, but not in murine RAW264.7 cells. Biocell. 2009;33(2):107\u201314.","journal-title":"Biocell"},{"issue":"7","key":"1386_CR100","doi-asserted-by":"publisher","first-page":"e100871","DOI":"10.1371\/journal.pone.0100871","volume":"9","author":"T Leuenberger","year":"2014","unstructured":"Leuenberger T, Pfueller CF, Luessi F, Bendix I, Paterka M, Prozorovski T, et al. Modulation of dendritic cell immunobiology via inhibition of 3-Hydroxy-3-Methylglutaryl-CoA (HMG-CoA) reductase. PLoS One. 2014;9(7):e100871.","journal-title":"PLoS One"},{"issue":"1","key":"1386_CR101","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/j.1365-2125.2011.03907.x","volume":"72","author":"L Bj\u00f6rkhem-Bergman","year":"2011","unstructured":"Bj\u00f6rkhem-Bergman L, Lindh JD, Bergman P. What is a relevant statin concentration in cell experiments claiming pleiotropic effects? Br J Clin Pharmacol. 2011;72(1):164\u20135.","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"1386_CR102","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1189\/jlb.0205064","volume":"79","author":"A Yilmaz","year":"2005","unstructured":"Yilmaz A, Reiss C, Weng A, Cicha I, Stumpf C, Steinkasserer A, et al. Differential effects of statins on relevant functions of human monocyte-derived dendritic cells. J Leukoc Biol. 2005;79(3):529\u201338.","journal-title":"J Leukoc Biol"},{"issue":"9","key":"1386_CR103","doi-asserted-by":"publisher","first-page":"e003976","DOI":"10.1161\/JAHA.116.003976","volume":"5","author":"J Frosteg\u00e5rd","year":"2016","unstructured":"Frosteg\u00e5rd J, Zhang Y, Sun J, Yan K, Liu A. Oxidized Low-Density lipoprotein (OxLDL)-Treated dendritic cells promote activation of T cells in human atherosclerotic plaque and Blood, which is repressed by statins: MicroRNA let-7c is integral to the effect. J Am Heart Assoc. 2016;5(9):e003976.","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"1386_CR104","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.atherosclerosis.2003.10.002","volume":"172","author":"A Yilmaz","year":"2004","unstructured":"Yilmaz A, Reiss C, Tantawi O, Weng A, Stumpf C, Raaz D, et al. HMG-CoA reductase inhibitors suppress maturation of human dendritic cells: new implications for atherosclerosis. Atherosclerosis. 2004;172(1):85\u201393.","journal-title":"Atherosclerosis"},{"key":"1386_CR105","doi-asserted-by":"publisher","first-page":"102177","DOI":"10.1016\/j.ceb.2023.102177","volume":"83","author":"S Wilmes","year":"2023","unstructured":"Wilmes S, K\u00fcmmel D. Insights into the role of the membranes in Rab GTPase regulation. Curr Opin Cell Biol. 2023;83:102177.","journal-title":"Curr Opin Cell Biol"},{"key":"1386_CR106","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s10787-015-0252-1","volume":"23","author":"DM de Oliveira","year":"2015","unstructured":"de Oliveira DM, de Oliveira EML, Ferrari MFR, Semedo P, Hiyane MI, Cenedeze MA, et al. Simvastatin ameliorates experimental autoimmune encephalomyelitis by inhibiting Th1\/Th17 response and cellular infiltration. Inflammopharmacology. 2015;23:343\u201354.","journal-title":"Inflammopharmacology"},{"issue":"9","key":"1386_CR107","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/j.imbio.2016.05.010","volume":"221","author":"DA Chistiakov","year":"2016","unstructured":"Chistiakov DA, Orekhov AN, Bobryshev YV. Immune-inflammatory responses in atherosclerosis: role of an adaptive immunity mainly driven by T and B cells. Immunobiology. 2016;221(9):1014\u201333.","journal-title":"Immunobiology"},{"issue":"26","key":"1386_CR108","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.2174\/1381612829666230904150808","volume":"29","author":"S Akhter","year":"2023","unstructured":"Akhter S, Tasnim FM, Islam MN, Rauf A, Mitra S, Emran TB, et al. Role of Th17 and IL-17 cytokines on inflammatory and auto-immune diseases. Curr Pharm Des. 2023;29(26):2078\u201390.","journal-title":"Curr Pharm Des"},{"issue":"6","key":"1386_CR109","doi-asserted-by":"publisher","first-page":"e32384","DOI":"10.1097\/MD.0000000000032384","volume":"102","author":"G Yang","year":"2023","unstructured":"Yang G, Qiu Y. Effects of amlodipine combined with atorvastatin on Th17\/Treg imbalance and vascular microcirculation in hypertensive patients with atherosclerosis: a double-blind, single-center randomized controlled trial. Medicine (Baltimore). 2023;102(6):e32384.","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"1386_CR110","doi-asserted-by":"publisher","first-page":"559","DOI":"10.3390\/jpm12040559","volume":"12","author":"MJ Kwon","year":"2022","unstructured":"Kwon MJ, Kim J-H, Kim JH, Park H-R, Kim NY, Hong S, et al. Incident rheumatoid arthritis following statin use: from the view of a National Cohort Study in Korea. J Pers Med. 2022;12(4):559.","journal-title":"J Pers Med"},{"issue":"37","key":"1386_CR111","doi-asserted-by":"publisher","first-page":"e35088","DOI":"10.1097\/MD.0000000000035088","volume":"102","author":"C Ren","year":"2023","unstructured":"Ren C, Li M. The efficacy of statins in the treatment of rheumatoid arthritis: a systematic review and meta-analysis. Medicine. 2023;102(37):e35088.","journal-title":"Medicine"},{"key":"1386_CR112","first-page":"101684","volume":"38","author":"T Takano","year":"2022","unstructured":"Takano T, Takeda K, Nakamura S, Akiyama G, Ando N, Komori M. A case of autoimmune pulmonary alveolar proteinosis with severe respiratory failure treated with segmental lung lavage and oral statin therapy. Respir Med Case Rep. 2022;38:101684.","journal-title":"Respir Med Case Rep"},{"issue":"2","key":"1386_CR113","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s10067-019-04856-z","volume":"39","author":"W Masson","year":"2020","unstructured":"Masson W, Rossi E, Mora-Crespo LM, Cornejo-Pe\u00f1a G, Pessio C, Gago M, et al. Cardiovascular risk stratification and appropriate use of Statins in patients with systemic lupus erythematosus according to different strategies. Clin Rheumatol. 2020;39(2):455\u201362.","journal-title":"Clin Rheumatol"},{"issue":"6","key":"1386_CR114","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1097\/CRD.0000000000000383","volume":"29","author":"CA Ballarano","year":"2021","unstructured":"Ballarano CA, Frishman WH. Cardiovascular disease in patients with systemic lupus erythematosus: potential for improved primary prevention with statins. Cardiol Rev. 2021;29(6):323\u20137.","journal-title":"Cardiol Rev"},{"issue":"4","key":"1386_CR115","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1007\/s10787-023-01240-x","volume":"31","author":"HM Al-Kuraishy","year":"2023","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Saad HM, Batiha GE-S. The potential therapeutic effect of statins in multiple sclerosis: beneficial or detrimental effects. Inflammopharmacology. 2023;31(4):1671\u201382.","journal-title":"Inflammopharmacology"},{"issue":"2","key":"1386_CR116","doi-asserted-by":"publisher","first-page":"303","DOI":"10.2478\/acph-2022-0018","volume":"72","author":"ANA Vavlukis","year":"2022","unstructured":"Vavlukis ANA, Vavlukis M, Dimovski A, Petrushevska G, Eftimov A, Domazetovska S, et al. Anti-inflammatory and Immunomodulatory effects of Rosuvastatin in patients with low-to-moderate cardiovascular risk. Acta Pharm. 2022;72(2):303\u201315.","journal-title":"Acta Pharm"},{"issue":"17","key":"1386_CR117","first-page":"e1729","volume":"101","author":"MM Almramhi","year":"2023","unstructured":"Almramhi MM, Finan C, Storm CS, Schmidt AF, Kia DA, Coneys R, et al. Exploring the role of plasma lipids and Statin interventions on multiple sclerosis risk and severity. Mendelian Randomization Study. 2023;101(17):e1729\u201340.","journal-title":"Mendelian Randomization Study"},{"issue":"5","key":"1386_CR118","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1097\/COH.0000000000000752","volume":"17","author":"KV Fitch","year":"2022","unstructured":"Fitch KV, Fulda ES, Grinspoon SK. Statins for primary cardiovascular disease prevention among people with HIV: emergent directions. Curr Opin HIV AIDS. 2022;17(5):293\u2013300.","journal-title":"Curr Opin HIV AIDS"},{"issue":"1","key":"1386_CR119","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s12885-023-10645-4","volume":"23","author":"T Selvin","year":"2023","unstructured":"Selvin T, Berglund M, Lenhammar L, Jarvius M, Nygren P, Frykn\u00e4s M, et al. Phenotypic screening platform identifies Statins as enhancers of immune cell-induced cancer cell death. BMC Cancer. 2023;23(1):164.","journal-title":"BMC Cancer"},{"issue":"7","key":"1386_CR120","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1007\/s00109-022-02213-3","volume":"100","author":"L Meng","year":"2022","unstructured":"Meng L, Lu Y, Wang X, Sui W, Ge X, Zhong M, et al. Statin therapy protects against abdominal aortic aneurysms by inducing the accumulation of regulatory T cells in ApoE\u2212\/\u2212 mice. J Mol Med. 2022;100(7):1057\u201370.","journal-title":"J Mol Med"},{"issue":"5","key":"1386_CR121","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1097\/MCA.0000000000000255","volume":"26","author":"A Altaf","year":"2015","unstructured":"Altaf A, Qu P, Zhao Y, Wang H, Lou D, Niu N. NLRP3 inflammasome in peripheral blood monocytes of acute coronary syndrome patients and its relationship with statins. Coron Artery Dis. 2015;26(5):409\u201321.","journal-title":"Coron Artery Dis"},{"issue":"3","key":"1386_CR122","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1124\/mol.116.108100","volume":"92","author":"S Wang","year":"2017","unstructured":"Wang S, Xie X, Lei T, Zhang K, Lai B, Zhang Z, et al. Statins attenuate activation of the NLRP3 inflammasome by oxidized LDL or TNF\u03b1 in vascular endothelial cells through a PXR-Dependent mechanism. Mol Pharmacol. 2017;92(3):256\u201364.","journal-title":"Mol Pharmacol"},{"key":"1386_CR123","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.intimp.2019.05.006","volume":"73","author":"N Parsamanesh","year":"2019","unstructured":"Parsamanesh N, Moossavi M, Bahrami A, Fereidouni M, Barreto G, Sahebkar A. NLRP3 inflammasome as a treatment target in atherosclerosis: a focus on statin therapy. Int Immunopharmacol. 2019;73:146\u201355.","journal-title":"Int Immunopharmacol"}],"container-title":["Current Atherosclerosis Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-025-01386-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11883-025-01386-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-025-01386-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T09:01:51Z","timestamp":1768035711000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11883-025-01386-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,10]]},"references-count":123,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1386"],"URL":"https:\/\/doi.org\/10.1007\/s11883-025-01386-9","relation":{},"ISSN":["1534-6242"],"issn-type":[{"value":"1534-6242","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,10]]},"assertion":[{"value":"13 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"No animal or human subjects by the authors were used in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"8"}}